The Aftermath of the U.S. Supreme Court’s Loper Bright on Health Care Practice
Lawyers practicing in the Health Care industry who represent healthcare companies and government agencies are embarking on a period of uncertainty following the U.S. Supreme Court decision, Loper Bright Enterprises v. Raimondo (603 U.S. 369 [2024]) (“Loper”). At the New York State Bar Association’s Annual Meeting, the Health Law and Food, Drug, and Cosmetics Sections … Continued
